Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes

Clinica Chimica Acta

Volumn 413, Issue 5-6, 2012, Pages 533-536

  Hu, Dongxiao ^a   Tian, Ting ^a   Guo, Jing ^a   Wang, Hanzhi ^a   Chen, Danqing ^a   Dong, Minyue ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Follistatin like 3; Gestational diabetes; Myostatin; Placenta

Indexed keywords

FOLLISTATIN LIKE 3 PROTEIN; FOLLISTATIN RELATED PROTEIN; GLUCOSE; HEMOGLOBIN A1C; MYOSTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH BIRTH WEIGHT; HOMEOSTASIS MODEL ASSESMENT OF INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; PATHOGENESIS; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TISSUE LEVEL; WEIGHT GAIN; WESTERN BLOTTING;

ADULT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; FOLLISTATIN-RELATED PROTEINS; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84856213419     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.10.029     Document Type: Article

References (18)

1. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25(10):1862-1868.
2. Lee A.J., Hiscock R.J., Wein P., et al. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007, 30(4):878-883.
3. Thadhani R., Powe C.E., Tjoa M.L., et al. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care 2010, 33(3):664-669.
4. Sidis Y., Mukherjee A., Keutmann H., et al. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphoge- neticproteins. Endocrinology 2006, 147:3586-3597.
5. Mukherjee A., Sidis Y., Mahan A., et al. FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fathomeostasis in adults. Proc Natl Acad Sci U S A 2007, 104:1348-1353.
6. Nanda S., Savvidou M., Syngelaki A., et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011, 31(2):135-141.
7. Allen D.L., Hittel D.S., McPherron A.C. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc Feb. 28 2011, [Epub ahead of print] PubMed PMID: 21364474.
8. Petraglia F., De Vita D., Gallinelli A., et al. Abnormal concentration of maternal serum activin A in gestational diseases. J Clin Endocrinol Metab 1995, 80(2):558-561.
9. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28:1039-1057.
10. Wallace E.M., Schneider-Kolsky M.E., Edwards A., et al. Maternal serum activin A levels in association with intrauterine fetal growth restriction. BJOG 2003, 110(3):306-310.
11. Florio P., Ciarmela P., Luisi S., et al. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol Endocrinol 2002, 16(5):365-372.
12. Reddy A., Suri S., Sargent I.L., et al. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One 2009, 4(2):e4453.
13. Bersinger N.A., Smárason A.K., Muttukrishna S., et al. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy 2003, 22(1):45-55.
14. Mitchell M.D., Osepchook C.C., Leung K.C., et al. Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab 2006, 91(4):1434-1437.
15. Antony N., Bass J.J., McMahon C.D., et al. Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab 2007, 293(5):E1296-E1302.
16. Okamoto A., Endo H., Kalionis B., et al. IGFBP1 and follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006, 27(2-3):317-321.
17. Biron-Shental T., Schaiff W.T., Rimon E., et al. Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts. Placenta 2008, 29(1):51-57.
18. Peiris H.N., Ponnampalam A.P., Osepchook C.C., et al. Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab 2010, 298(4):E854-E861.